FDA Warning: Hidden Dangers of Smuggled Tirzepatide The FDA may be about to change everything for peptide research. Secretary RFK Jr. announced plans to move 14 peptides from Category 2 to Category 1. That means FDA recognized. Potentially prescribable through FDA to Remove 12 Popular Peptides from the Category 2 Do Not Compound List Frier Levitt FDA Peptide Update 2026: Removal from Do Not Compound List and What It Means for Pharmacies Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health